Tag Archives: adverse effects

Case study on the voice of the patient for the Pharma industry

Pharmaceutical companies are extending their Voice of the Patient projects to include social media: comments on web forums, surveys, Twitter, and more.

The goal of the proof of concept ordered by one particular pharmaceutical company in Spain was to: ” Collect and analyze the voice of the patient, both quantitatively and qualitatively, from the channels where it is expressed”, including social networks like web forums, Facebook, Twitter, and other systems.

For the pharma industry, it is essential to listen and understand the feedback that their current and potential customers communicate through various means and touchpoints.

Web forums, for instance, gather millions of posts, and function as a meeting point for patients where support, experiences, and wisdom are shared with peers, family members, and friends.

Continue reading


Our experience on Adverse Drug Reactions (ADR) identification at TAC2017

MeaningCloud and LaBDA research group were present at the TAC 2017 conference held on November 13th – 14th at NIST headquarters in Washington. In the Text Analysis Conferences, research groups from all over the world were invited to develop software systems to tackle text analytics-related problems. This year, one task was devoted to the automatic identification of adverse drug reactions (ADRs) appearing in drug labels, including features defining the ADR, such as its severity or if it is characteristic of a drug class instead of just a given drug. There has been a specific subtask to link the identified ADRs with their corresponding MedDRA codes and lexical terms. More than 10 research teams have taken part in the project, all of them applying some kind of deep learning approach to the problem. Results show that it is possible to reach 85% accuracy when identifying ADRs.

We were delighted to present our text analytics-based system for ADRs identification on drug labels, which combines natural language processing and machine learning algorithms. The system has been built as a joint effort between MeaningCloud and LaBDA research group at the Universidad Carlos III de Madrid. Identifying ADRs is a basic task for pharmacovigilance, and that is the reason why the Federal Drug Administration (FDA) is involved in the funding and definition of the ADRs identification tasks in the framework of the Text Analysis Conferences. We have learned a lot these days (e.g., a BiLSTM deep neural network is the best choice for the purpose), and shared pleasant moments with our colleagues at Washington. We hope to be able to attend next year’s edition, which will focus on the extraction of drug-drug interactions (DDI), another interesting task aimed at detecting situations where the use of a combination of drugs may lead to an adverse effect.